Y-mAbs Therapeutics, Inc.

YMABDelisted Sep 16, 2025

Industry: Pharmaceutical Preparations
SEC CIK: 0001722964

SEC filings (opens in a new tab)

Y-mAbs Therapeutics, Inc. was delisted on Sep 16, 2025; its insiders filed their last Form 4 on Sep 19, 2025; 97 institutions reported holding it in 13F filings for Q2 2025, worth $125.9M in total; no superinvestor held it.

Superinvestors holding YMAB, Q2 2025

See all superinvestors

No superinvestor reported holding YMAB in Q2 2025.